Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusVirologyPandemicIntensive care medicineCoronavirus InfectionsPneumoniaMEDLINEInternal medicineOutbreakInfectious disease (medical specialty)Political scienceLawDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research